Diagnostic Accuracy of Right Ventricular Dysfunction Markers in Normotensive Emergency Department Patients With Acute Pulmonary Embolism
- PMID: 26973178
- DOI: 10.1016/j.annemergmed.2016.01.027
Diagnostic Accuracy of Right Ventricular Dysfunction Markers in Normotensive Emergency Department Patients With Acute Pulmonary Embolism
Abstract
Study objective: We determine the diagnostic accuracy of goal-directed echocardiography, cardiac biomarkers, and computed tomography (CT) in early identification of severe right ventricular dysfunction in normotensive emergency department patients with pulmonary embolism compared with comprehensive echocardiography.
Methods: This was a prospective observational study of consecutive normotensive patients with confirmed pulmonary embolism. Investigators, blinded to clot burden and biomarkers, performed qualitative goal-directed echocardiography for right ventricular dysfunction: right ventricular enlargement (diameter greater than or equal to that of the left ventricle), severe right ventricular systolic dysfunction, and septal bowing. Brain natriuretic peptide and troponin cutoffs of greater than or equal to 90 pg/mL and greater than or equal to 0.07 ng/mL and CT right ventricular:left ventricular diameter ratio greater than or equal to 1.0 were also compared with comprehensive echocardiography.
Results: One hundred sixteen normotensive pulmonary embolism patients (111 confirmed by CT, 5 by ventilation-perfusion scan) were enrolled. Twenty-six of 116 patients (22%) had right ventricular dysfunction on comprehensive echocardiography. Goal-directed echocardiography had a sensitivity of 100% (95% confidence interval [CI] 87% to 100%), specificity of 99% (95% CI 94% to 100%), positive likelihood ratio (+LR) of 90.0 (95% CI 16.3 to 499.8), and negative likelihood ratio (-LR) of 0 (95% CI 0 to 0.13). Brain natriuretic peptide had a sensitivity of 88% (95% CI 70% to 98%), specificity of 68% (95% CI 57% to 78%), +LR of 2.8 (95% CI 2.0 to 3.9), and -LR of 0.17 (95% CI 0.06 to 0.43). Troponin had a sensitivity of 62% (95% CI 41% to 80%), specificity of 93% (95% CI 86% to 98%), +LR of 9.2 (95% CI 4.1 to 20.9), and -LR of 0.41 (95% CI 0.24 to 0.62). CT had a sensitivity of 91% (95% CI 72% to 99%), specificity of 79% (95% CI 69% to 87%), +LR of 4.3 (95% CI 2.8 to 6.7), and -LR of 0.11 (95% CI 0.03 to 0.34).
Conclusion: Goal-directed echocardiography was highly accurate for early severe right ventricular dysfunction identification and pulmonary embolism risk-stratification. Brain natriuretic peptide was sensitive but less specific, whereas troponin had lower sensitivity but higher specificity. CT had good sensitivity and moderate specificity.
Copyright © 2016 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Prognostic Value of Right Ventricular Dysfunction Markers for Serious Adverse Events in Acute Normotensive Pulmonary Embolism.J Emerg Med. 2017 Feb;52(2):137-150. doi: 10.1016/j.jemermed.2016.09.002. Epub 2016 Oct 15. J Emerg Med. 2017. PMID: 27751702
-
Regional right ventricular dysfunction in acute pulmonary embolism: relationship with clot burden and biomarker profile.Int J Cardiovasc Imaging. 2016 Mar;32(3):389-98. doi: 10.1007/s10554-015-0780-1. Epub 2015 Oct 1. Int J Cardiovasc Imaging. 2016. PMID: 26428674
-
Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism.Crit Care Med. 2006 Nov;34(11):2773-80. doi: 10.1097/01.CCM.0000241154.55444.63. Crit Care Med. 2006. PMID: 16943732
-
Importance of cardiac biomarkers in risk stratification in acute pulmonary embolism.Cardiol J. 2008;15(1):17-20. Cardiol J. 2008. PMID: 18651380 Review.
-
Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis.Eur Heart J. 2019 Mar 14;40(11):902-910. doi: 10.1093/eurheartj/ehy873. Eur Heart J. 2019. PMID: 30590531 Free PMC article.
Cited by
-
Redefining biomarkers in heart failure.Heart Fail Rev. 2018 Mar;23(2):237-253. doi: 10.1007/s10741-018-9683-2. Heart Fail Rev. 2018. PMID: 29511896 Review.
-
A predictive tool for the assessment of right ventricular dysfunction in non-high-risk patients with acute pulmonary embolism.BMC Pulm Med. 2021 Jan 28;21(1):42. doi: 10.1186/s12890-020-01380-8. BMC Pulm Med. 2021. PMID: 33509132 Free PMC article. Clinical Trial.
-
Accuracy of focused cardiac ultrasound interpretation among emergency and critical care medicine residents in Ethiopia: A multi-center cross-sectional study.Afr J Emerg Med. 2024 Sep;14(3):150-155. doi: 10.1016/j.afjem.2024.06.002. Epub 2024 Jun 19. Afr J Emerg Med. 2024. PMID: 39005756 Free PMC article.
-
Electrocardiographic findings associated with early clinical deterioration in acute pulmonary embolism.Acad Emerg Med. 2022 Oct;29(10):1185-1196. doi: 10.1111/acem.14554. Epub 2022 Jul 20. Acad Emerg Med. 2022. PMID: 35748352 Free PMC article.
-
Quality of life 1 month after acute pulmonary embolism in emergency department patients.Acad Emerg Med. 2023 Aug;30(8):819-831. doi: 10.1111/acem.14692. Epub 2023 Mar 8. Acad Emerg Med. 2023. PMID: 36786661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical